
Nephrologist

No OPD information available
Calcinosis
Calciphylaxis
Hyperparathyroidism
Chronic Kidney Disease
Kidney Transplant
Malnutrition
Parathyroidectomy
Rickets
Asymptomatic Bacteriuria
End-Stage Renal Disease (ESRD)
Hypercalcemia
Hypertension
Interstitial Nephritis
Metabolic Acidosis
Milk-Alkali Syndrome
Osteitis Fibrosa
Osteoporosis
Parathyroid Hyperplasia
Urinary Tract Infection (UTI)
Nigel D. Toussaint is a doctor who helps people with different health problems like kidney issues, bone diseases, and infections. He is very skilled in treating conditions such as calcinosis, hyperparathyroidism, and chronic kidney disease. Nigel also helps patients who need kidney transplants and those who have malnutrition.
Nigel is good at talking to his patients and making them feel comfortable. Patients trust him because he listens to their concerns and explains things clearly. He uses simple language that everyone can understand.
Nigel stays updated with the latest medical knowledge by reading research articles and attending conferences. This helps him provide the best care for his patients. He works well with other doctors and healthcare professionals to give patients the best treatment possible.
Nigel's work has made a positive impact on many patients' lives. For example, his research on atrial fibrillation in people with kidney disease has helped improve how doctors manage this condition. He has also conducted clinical trials to find better treatments for anemia in people with chronic kidney disease.
One of Nigel's notable publications is about managing atrial fibrillation in people with advanced kidney disease. This shows his expertise in the field. He has also been involved in a clinical trial to study a new treatment for anemia in people with chronic kidney disease.
In summary, Nigel D. Toussaint is a caring and knowledgeable doctor who helps people with various health issues. He communicates well with patients, stays updated with the latest medical knowledge, works closely with other medical professionals, and has made significant contributions to improving patient care through his research and clinical trials.
Enrollment Status: Completed
Published: April 02, 2024
Intervention Type: Drug
Study Drug:
Study Phase: Phase 3
